Research Topic · Peer-Reviewed

Antibody Production

Antibody production is the immunological process by which B lymphocytes generate immunoglobulins, antigen-specific glycoproteins that recognize and neutralize pathogens and other foreign molecules. It begins when a B cell encounters its cognate antigen and, typically with helper T-cell co-stimulation and cytokine si…

Curated from this journal's research 📚 7 peer-reviewed articles cited Cited 20× across the literature 🔖 ISSN 2641-4538 🗓 Reviewed June 2026

Overview

Antibody production is the immunological process by which B lymphocytes generate immunoglobulins, antigen-specific glycoproteins that recognize and neutralize pathogens and other foreign molecules. It begins when a B cell encounters its cognate antigen and, typically with helper T-cell co-stimulation and cytokine signals, becomes activated, proliferates, and differentiates into antibody-secreting plasma cells and memory B cells. Within germinal centers, somatic hypermutation and affinity maturation refine binding strength, while class-switch recombination tailors antibody isotype to effector function, producing the IgM, IgG, IgA, and other classes that mediate neutralization, opsonization, and complement activation. This process underlies protective immunity and is the basis of vaccination, where post-vaccination seroprevalence reflects the magnitude and durability of induced antibody responses, and immune modulators such as interferon-gamma can shape the broader response. Antibody biology spans clinical and diagnostic applications, including antibody-mediated and autoimmune syndromes such as myasthenia and antisynthetase-antibody disease, antibody-based detection in infections and immunodiagnosis, and the engineering of monoclonal antibodies, including single-chain variable-fragment constructs, for targeted recognition and therapy. Antibody trajectories also feature in models of population immunity and in the pathology of immune dysregulation, including thrombocytopenic conditions. As a scholarly topic, antibody production integrates cellular immunology, molecular biology, and biotechnology to explain humoral defense, support diagnosis and vaccine development, and enable the design of antibody therapeutics for infectious, autoimmune, and neoplastic disease.

Research published in this journal

7 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 7 articles above have been cited 20 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Antibody Production, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Public Health International (ISSN 2641-4538).

Journal editorial board
Javad Javan-Noughabi · United Kingdom Evelyn O Talbott · United States Zainab Taha · United Arab Emirates

This page summarises published research for orientation; it is not medical or professional advice.